Symbiox Investment & Trading Co. Ltd. reported a net profit of ₹15.23 lakh for the year ended March 31, 2026, a decline from ₹19.19 lakh in the previous year. Revenue from operations fell to ₹160.29 lakh from ₹276.36 lakh in FY25. The board of directors approved the audited financial results during a meeting held on May 23, 2026.

Financial Performance

For the year ended March 31, 2026, total income stood at ₹160.52 lakh. Total expenses decreased to ₹139.94 lakh from ₹250.86 lakh in the prior year. Profit before tax for FY26 was ₹20.58 lakh, compared to ₹25.93 lakh in FY25. The basic earnings per share (EPS) for the year were ₹0.049, down from ₹0.061 in the previous year.

The financial performance for the quarter ended March 31, 2026, showed a net profit of ₹1.22 lakh on a revenue of ₹82.73 lakh. In comparison, the quarter ended March 31, 2025, had reported a net loss of ₹29.94 lakh.

Balance Sheet and Cash Flow

As of March 31, 2026, the company's total assets were valued at ₹3,197.60 lakh, slightly higher than ₹3,196.59 lakh in the previous year. Total equity stood at ₹3,187.63 lakh, while total liabilities were reported at ₹9.97 lakh.

The cash flow statement for the year ended March 31, 2026, showed a net cash flow from operating activities of ₹272.59 lakh. Net cash used in investing activities was ₹261.29 lakh. Consequently, the net cash flow during the year was ₹11.30 lakh, bringing the closing cash and cash equivalents to ₹117.18 lakh.

Board Appointments

The board approved the re-appointment of Mr. Akhil Agarwal, Practising Company Secretary, as the Secretarial Auditor for FY 2026-27. The board also re-appointed Mrs. Shikha Singhal Chartered Accountants as the Internal Auditor for the same financial year. The statutory auditors issued an unmodified opinion on the audited financial results.

Symbiox Investment & Trading Co. Ltd. has intimated stock exchanges of a forthcoming Board of Directors meeting, scheduled for Saturday, May 23, 2026, at 1:30 P.M. at the company's registered office in Kolkata. The notice, dated May 14, 2026, has been filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has been communicated to the Metropolitan Stock Exchange of India Limited, The Calcutta Stock Exchange Limited, and The Bombay Stock Exchange Limited.

Board Meeting Agenda

The board meeting has been convened to transact several key matters. The following agenda items are scheduled for consideration:

Key Regulatory Context

The approval of financial results will be carried out under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs the disclosure of financial results by listed entities. The board will consider both the audited financial results and the associated limited review report for the quarter and full year ended March 31, 2026.

Auditor Appointments for FY 2026-27

Among the notable agenda items are two auditor appointments for the upcoming financial year. The board will consider appointing Mr. Akhil Agarwal, Practising Company Secretary, as Secretarial Auditor of the company for FY 2026-27. Additionally, the appointment of Mrs. Shikha Singhal, Chartered Accountant, as Internal Auditor for FY 2026-27 will also be deliberated upon.

The intimation was signed by Khushboo Pitti, Company Secretary and Compliance Officer (M. No. A25950), on behalf of Symbiox Investment & Trading Co. Ltd.